| 1 | 10854425 | Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA. | J Biol Chem | 2000 Sep 1 |
1 |
| 2 | 16418324 | Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. | Blood | 2006 May 15 |
1 |
| 3 | 18559347 | The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. | J Biol Chem | 2008 Aug 15 |
1 |
| 4 | 23160194 | GSK3β mediates muscle pathology in myotonic dystrophy. | J Clin Invest | 2012 Dec |
2 |
| 5 | 24179176 | High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. | Hum Mol Genet | 2014 Mar 15 |
1 |
| 6 | 24752171 | Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. | Nat Commun | 2014 Apr 22 |
1 |
| 7 | 26169831 | Hypogonadism Associated with Cyp19a1 (Aromatase) Posttranscriptional Upregulation in Celf1 Knockout Mice. | Mol Cell Biol | 2015 Sep |
2 |
| 8 | 27255754 | RNA-binding protein CUGBP1 regulates insulin secretion via activation of phosphodiesterase 3B in mice. | Diabetologia | 2016 Sep |
3 |
| 9 | 28559429 | RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner. | Mol Cell Biol | 2017 Aug 15 |
4 |
| 10 | 33503591 | Glycyrrhetinic acid remodels the tumor microenvironment and synergizes with doxorubicin for breast cancer treatment in a murine model. | Nanotechnology | 2021 Apr 30 |
1 |
| 11 | 35234905 | Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis. | Nucleic Acids Res | 2022 Mar 21 |
1 |
| 12 | 35387552 | Guizhi Fuling pill attenuates liver fibrosis <i>in vitro</i> and <i>in vivo</i> via inhibiting TGF-β1/Smad2/3 and activating IFN-γ/Smad7 signaling pathways. | Bioengineered | 2022 Apr |
3 |